Joel Greenblatt acquired 11.4 Thousand Resmed shares worth $2.09 Million. That's 0.04% of their equity portfolio (572nd largest holding). The first Resmed trade was made in Q4 2011. Since then Joel Greenblatt bought shares twenty more times and sold shares on 22 occasions. The investor's estimated purchase price is $2.18 Million, resulting in a loss of 4.3%.